Evaluation of apoptosis induced by capecitabine in combination with graphene oxide nanoparticles in hamster buccal pouch carcinoma | ||||
| Al-Azhar Journal of Dental Science | ||||
| Volume 28, Issue 3, July 2025, Page 457-465 PDF (1.68 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ajdsm.2024.256872.1489 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ahmed Alnos Aly  1; Khaled Mohamed Afify2; Mohamed Mahmoud Ahmed 3
| ||||
| 1Assistant lecturer, Oral and Dental Pathology department, Faculty of Dental Medicine, Assiut, Al-Azhar University, Egypt. | ||||
| 2Assistant Professor, Department of Oral and Dental Pathology Faculty of Dental Medicine, Assiut, Al-Azhar University, Egypt. | ||||
| 3Professor and head of the Oral and Dental Pathology Department, Faculty of Dental Medicine (Boys Cairo), Al-Azhar University, Egypt. | ||||
| Abstract | ||||
| Objective: current research is directed to assess apoptosis induced by capecitabine in combination with graphene oxide (GO) nanoparticles in hamster buccal pouch (HBP) carcinoma. Material & methods: 40 Syrian male hamsters 5 weeks old, weighing 80-120g, had been separated into 4 groups. GI: Animals left untreated. GII: Animals had been painted with 0.5% 7, 12-dimethylbenz (a) anthracene (DMBA) (3 times/week/14weeks). GIII: DMBA was applied followed by administration of capecitabine orally, 600mg/kg/day, daily for a week followed by a week of rest, then a week of treatment. GIV: Animals were painted with DMBA then capecitabine was administered in addition to GO, which was administered by injection directly into the tumor at a dose of 2mg/kg/day, daily for 3 weeks. At end of experiment, animals had been euthanized, then all right pouches were excised, and divided into two parts for further histologic and flowcytometric (FCM) evaluation. Results: Gross observation of GIV confirmed reduction in size of exophytic masses as compared to GIII. Histologic observations of GIV indicated that 5 animals exhibited well-differentiated SCC, 4 animals exhibited severe dysplasia & 1 animal exhibited moderate dysplasia compared to GIII which indicated that 6 animals exhibited well-differentiated SCC & 4 animals exhibited severe dysplasia. FCM detection of apoptosis explained that the percentage of apoptotic cells in GIV had been significantly higher than in GIII. Conclusions: The combination of capecitabine & GO resulted in a synergistic antitumor effect by inhibiting tumor progression and inducing apoptosis more effectively than capecitabine alone in induced HBP carcinoma. | ||||
| Keywords | ||||
| Capecitabine; Graphene oxide; HBP carcinoma | ||||
|
Statistics Article View: 11 PDF Download: 8 |
||||
